Paclitaxel-Loaded Lipid Nanoparticles Prepared by Solvent Injection or Ultrasound Emulsification

REFERENCES

• Arıca B., Lamprecht A. In-vitro evaluation of betamethasone loaded nanoparticles. Drug Development and Industrial Pharmacy 2005; 31: 19–25
   PubMed Web of Science ®Google Scholar
• Attawia M. A., Borden M. D., Herbert K. M., Katti D. S., Asrari F., Uhrich K. E., Laurencin C. T. Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release system. Journal of Controlled Release 2001; 71: 193–202
   PubMed Web of Science ®Google Scholar
• Barichello J. M., Morishita M., Takayama K., Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Development and Industrial Pharmacy 1999; 25: 471–476
   PubMed Web of Science ®Google Scholar
• Cavalli R., Aquilano D., Carrlotti M. E., Gasco M. R. Study by X-ray powder diffraction and differential scanning calorimetry of two model drugs, phenothiazine and nifedipine, incorporated into lipid nanoparticles. European Journal of Pharmaceutics & Biopharmaceutics 1995; 41: 329–333
   Web of Science ®Google Scholar
• Cavalli R., Caputo O., Gasco M. R. Preparation and characterization of solid lipid nanospheres containing paclitaxel. European Journal of Pharmaceutical Sciences 2000; 10: 305–309
   PubMed Web of Science ®Google Scholar
• Cavalli R., Gasco M. R., Barresi A. A., Rovero G. Evaporative drying of aqueous dispersions of solid lipid nanoparticles. Drug Development and Industrial Pharmacy 2001; 27: 919–924
   PubMed Web of Science ®Google Scholar
• Chen D. B., Yang T. Z., Lu W. L., Zhang Q. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chemical Pharmaceutical Bulletin 2001; 49: 1444–1447
   PubMed Web of Science ®Google Scholar
• Clas S. D., Dalton C. R., Hancock B. C. Differential scanning calorimetry: applications in drug development. Pharmaceutical Science Technology Today 1999; 2: 311–320
   PubMedGoogle Scholar
• Garcia-Fuentes M., Torres D., Martin-Pastor M., Alonso M. J. Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles. Langmuir 2004; 20: 8839–8845
   PubMed Web of Science ®Google Scholar
• Hou D., Xie C., Huang K., Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003; 24: 1781–1785
   PubMed Web of Science ®Google Scholar
• Jenning V., Lippacher A., Gohla S. H. Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization. Journal of Microencapsulation 2002; 19: 1–10
   PubMed Web of Science ®Google Scholar
• Lamprecht A., Ubrich N., Yamamoto H., Schäfer U., Takeuchi H., Lehr C. M., Maincent P., Kawashima Y. Design of rolipram loaded nanoparticles: comparison of two preparation methods. Journal of Controlled Release 2001; 71: 297–306
   PubMed Web of Science ®Google Scholar
• Langguth P., Hanafy A., Frenzel D., Grenier P., Nhamias A., Ohlig T., Vergnault G., Spahn-Langguth H. Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound. Drug Development and Industrial Pharmacy 2005; 31: 319–329
   PubMed Web of Science ®Google Scholar
• Liu J., Zhu J., Du Z., Qin B. Preparation and pharmacokinetic evaluation of Tashinone IIA solid lipid nanoparticles. Drug Development and Industrial Pharmacy 2005; 31: 551–556
   PubMed Web of Science ®Google Scholar
• Miglietta A., Cavalli R., Bocca C., Gabriel L., Gasco M. R. Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. International Journal of Pharmaceutics 2000; 210: 61–67
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D., Allémann E., Doelker E., Fessi H. A mechanistic study of the formation of polymer nanoparticles by the emulsification-diffusion technique. Colloid Polymer Science 1997; 275: 640–647
   Web of Science ®Google Scholar
• Schubert M. A., Müller-Goymann C. C. Solvent injection as a new approach for manufacturing lipid nanoparticles: evaluation of the method and process parameters. European Journal of Pharmaceutics & Biopharmaceutics 2003; 55: 125–131
   PubMed Web of Science ®Google Scholar
• Serpe L., Catalano M. G., Cavalli R., Ugazio E., Bosco O., Canaparo R., Muntoni E., Frairia R., Gasco M. R., Eandi M., Zara G. P. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. European Journal of Pharmaceutics & Biopharmaceutics 2004; 58: 673–680
   PubMed Web of Science ®Google Scholar
• Shirazi F. H., Bahrami G., Stewart D. J., Tomiak E., Delorme F., Noel D., Goel R. A rapid reversed phase high performance liquid chromatographic method for determination of PX (VP-16) in human plasma. Journal of Pharmaceutical and Biomedical Analysis 2001; 25: 353–356
   PubMed Web of Science ®Google Scholar
• Singla A. K., Garg A., Aggarwal D. Paclitaxel and its formulations. International Journal of Pharmaceutics 2002; 235: 179–192
   PubMed Web of Science ®Google Scholar
• Yang S. C., Zhu J. B. Preparation and characterization of camptothecin solid lipid nanoparticles. Drug Development and Industrial Pharmacy 2002; 28: 265–274
   PubMed Web of Science ®Google Scholar
• Youan Bi-Botti C., Hussain A., Nguyen N. T. Evaluation of sucrose esters as alternative surfactants in microencapsulation of proteins by the solvent evaporation method. AAPS Pharm Sci 2003; 5, Article 22
   PubMedGoogle Scholar
• Zhao L., Feng S. S. Effects of lipid chain unsaturation and headgroup type on molecular interactions between paclitaxel and phospholipid within model biomembrane. Journal of Colloid and Interface Science 2005; 285: 326–335
   PubMed Web of Science ®Google Scholar
• Zhao L., Feng S. S., Go M. L. Investigation of molecular interactions between paclitaxel and DPPC by Langmuir film balance and differential scanning calorimetry. Journal of Pharmaceutical Sciences 2004; 93: 86–98
   PubMed Web of Science ®Google Scholar